Bristol Myers Squibb and Microsoft have launched a digital health collaboration aimed at accelerating early detection of lung cancer using AI-driven radiology workflows. The initiative will deploy FDA ...
Microsoft and Bristol Myers Squibb join forces to advance AI lung cancer detection, aiming to improve early diagnosis and ...
Bristol Myers Squibb (BMY) stock is in focus as the company partners with Microsoft (MSFT) for the early detection of lung ...
A team of researchers from the University of Chicago's Pritzker School of Molecular Engineering (UChicago PME) has used Quantum Machine Learning (QML) to identify cancer early.
WALTHAM, Mass., Nov. 20, 2025 /PRNewswire/ -- Mercy BioAnalytics, Inc., a pioneer in blood-based detection of early-stage cancer, today announced data from a groundbreaking study leveraging samples ...
Electronic nose breath analysis achieved 80-92% accuracy for detecting lung cancer in patients with suspicious findings. Detection accuracy remained consistent across tumor characteristics, disease ...
NeXT Personal identifies circulating tumor DNA in 81% of early-stage lung adenocarcinoma cases, offering potential for better disease stratification and outcome prediction. Study: Ultrasensitive ctDNA ...
FREMONT, Calif.--(BUSINESS WIRE)--Personalis, Inc. (Nasdaq: PSNL), in collaboration with Professor Charles Swanton and his colleagues at London’s Francis Crick Institute and University College London, ...
According to a new study, the use of an artificial intelligence-based "You Only Look Once (YOLO)" algorithm showed high precision in detecting B lines on lung ultrasound (LUS) images, with substantial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results